Holiday shipping dates:
Last international orders dispatched: Friday 11th December
Last UK domestic orders dispatched: Wednesday 16th December
Following the holiday period, shipping will resume as normal from the week commencing Monday 4th January 2027
| Inventor | Institute |
|---|---|
| June L. Biedler, Barbara A. Spengler | Memorial Sloan-Kettering Cancer Center (MSK) |
| SKU: | 161937 |
|---|---|
| Product description: | SK-N-SH is a neuroblastoma cell line that displays epithelial morphology and grows in adherent culture. |
| Gender: | Female |
| Products or characteristics of interest: | Karyotype: The cell line is hyperdiploid human female (XX), with the modal chromosome number of 47. Normal chromosomes N9 and N22 are single. One copy of each of these chromosomes is structurally altered to form the two marker chromosomes 9q+ and 22q+., Chromosomes N7 is trisomic. Extra bands were found on one copy of chromosome N7, thereby forming a marker chromosome as described by R.C. Seeger. May have been translocated in part(s) to the q arms of chromosomes N9 and N22. Isoenzymes: AK-1, 1 ES-D, 1 G6PD, B GLO-I, 1 Me-2, 2 PGM1, 1 PGM3, 1 |
| Cat. #: | 161937 |
|---|---|
| Cancer types: | Neuroblastoma |
| Tissue: | Brain |
| Gender: | Female |
| Morphology: | Epithelial |
| Growth properties: | Adherent |
| Cancer Types In Detail: | Neuroblastoma |
| Primary citation: | Biedler et al. Cancer research. 33(11):2643-2652. PMID: 4748425. |
| Shipping conditions: | Dry Ice |
|---|---|
| Growth medium: | 1:1 mixture of ATCC-formulated Eagle’s Minimum Essential Medium, Catalog No. 30-2003, and F12 Medium then supplemented with fetal bovine serum to a final concentration of 10%. |
| Temperature: | 37° C |
| Atmosphere: | 5% CO2 in air |
| Storage medium: | Complete growth medium supplemented with 5% DMSO |
| Biosafety level: | 1 |
| References: |
Helson et al. 1975. Cancer Res. 35(9):2594-2599. PMID: 167965. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.